Choosing a Method for Epitope Mapping
  • Glenn E. Morris
Part of the Methods in Molecular Biology™ book series (MIMB, volume 66)


For most practical purposes, an epitope is easy to define as that part of an antigen involved in its recognition by an antibody (or, in the case of T-cell epitopes, by a T-cell receptor). Although simple chemical molecules, nucleic acids, and carbohydrates can all act as antigens, the term “epitope mapping” is usually applied to protein antigens, and is the process of locating the epitope on the protein surface or in the protein sequence. The simplicity is deceptive, however, and conceptual problems soon make their practical consequences felt. A considerable understanding of the principles of protein structure and protein folding, and some knowledge of the nature of the immune response may quickly become necessary for the correct interpretation of experimental epitope mapping results. The term “epitope mapping” has also been used to describe the attempt to determine all the major sites on a protein surface that can elicit an antibody response, at the end of which one might claim to have produced an “epitope map” of the protein antigen (1). This information might be very useful, for example, to someone wishing to produce antiviral vaccines. Implicit in this view of epitopes is that they are fixed and concrete structures on protein surfaces, which are few in number and uniquely capable of stimulating the immune system. Even if this is true for proteins in their native conformation, it is a limitation imposed by protein structure rather than the immune system, since additional immunogenic determinants are readily revealed by protein unfolding. This kind of “epitope map” also confuses the important distinction between antigenicity (the ability to recognize a specific antibody) and immunogenicity (the ability to produce antibodies in a given animal species). Most people would agree that epitopes should be defined by their antigenicity.


Antibody Binding Phage Display Peptide Library Individual Amino Acid Epitope Mapping 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Atassi, M. Z. (1984) Antigenic structure of proteins. Eur J. Biochem. 145, 1–20.PubMedCrossRefGoogle Scholar
  2. 2.
    Berzoksky, J. A. (1985) Intrinsic and extrinsic factors in protein antigenic structure. Science 219, 932–940.CrossRefGoogle Scholar
  3. 3.
    van Regenmortel, M. H. V. (1989) Structural and functional approaches to the study of protein antigenicity. Immunol Today 10, 266–272.PubMedCrossRefGoogle Scholar
  4. 4.
    Barlow, D. J., Edwards, M. S., and Thornton, J. M. (1986) Continuous and discontinuous protein antigenic determinants. Nature 322, 747–748.Google Scholar
  5. 5.
    Laver, W. G., Air, G. M., Webster, R. G., and Smith-Gill, S. J. (1990) Epitopes on protein antigens: misconceptions and realities. Cell 61, 553–556.PubMedCrossRefGoogle Scholar
  6. 6.
    Greenspan, N. S. (1992) Epitopes, paratopes and other topes: do immunologists know what they are talking about? Bull. Inst. Pasteur 90, 267–279.Google Scholar
  7. 7.
    Clark, E. A. and Ledbetter, J. A. (1994) How B-cells and T-cells talk to each other. Nature 367, 425–428.PubMedCrossRefGoogle Scholar
  8. 8.
    Thanh, L. T., Man, N. T., Mat, B., Tran, P. N., Ha, N. T. V., and Morris, G. E. (1991) Structural relationships between hepatitis B surface antigen in human plasma and dimers of recombinant vaccine: a monoclonal antibody study. Virus Res. 21, 141–154.PubMedCrossRefGoogle Scholar
  9. 9.
    Dore, I., Weiss, E., Altshuh, D., and van Regemnortel, M. H. V. (1988) Visualization by electron microscopy of the location of tobacco mosaic vuus epitopes reacting with monoclonal antibodies in enzyme immunoassay. Virology 162, 279–289.PubMedCrossRefGoogle Scholar
  10. 10.
    Stanley, K. K. (1988) Epitope mapping using pEX. Methods Mol. Biol. 4, 351–361.Google Scholar
  11. 11.
    Thanh, L. T., Man, N. T., Hori, S., Sewry, C. A., Dubowitz, V., and Morris, G. E. (1995) Characterization of genetic deletions in Becker Muscular Dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin. Am. J. Med. Genet. 58, 177–186.CrossRefGoogle Scholar
  12. 12.
    Lu, Z., Murray, K. S., van Cleave, V., LaVallie, E. R., Stahl, M. L., and McCoy, J. M. (1995) Expression of thioredoxin random peptide libraries on the Escherichia coli cell surface as functional fusions to flagellin. Bio/Technology 13, 366–372.PubMedCrossRefGoogle Scholar
  13. 13.
    Mattheakis, J. C., Bhatt, R. R., and Dower, W. J. (1994) An in vitro display system for identifying ligands from very large peptide libraries. Proc. Natl. Acad. Sci. USA 91, 9022–9026.PubMedCrossRefGoogle Scholar
  14. 14.
    Holmes, C. P., Adams, C. L., Kochersperger, L. M., Mortensen, R. B., and Aldwin, L. A. (1995) The use of light-directed combinatorial peptide synthesis in epitope mapping. Biopolymers 37, 199–211.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 1996

Authors and Affiliations

  • Glenn E. Morris
    • 1
  1. 1.MRIC Biotechnology GroupNorth East Wales InstituteWrexhamUK

Personalised recommendations